BioFlag Showcases Innovative Probiotic Solutions
BioFlag Co., Ltd., a leading probiotic manufacturer based in China, made headlines at the 2025 Vitafoods Europe exhibition held in Barcelona, Spain. The company proudly presented its scientifically validated probiotic solutions that have attracted considerable attention from both global media and industry professionals.
During the event, BioFlag highlighted its cutting-edge products, including clinically studied probiotic strains and ready-to-use products targeting various health benefits. These offerings focus on areas such as gut health, immune regulation, metabolic health, weight management, oral care, and emotional well-being. Furthermore, BioFlag introduced custom probiotic solutions designed to meet stringent European and American regulatory standards.
Among the key innovations showcased were several flagship probiotic strains:
1.
Bifidobacterium animalis subsp. lactis BL-99: Sourced from BioFlag's proprietary probiotic strain library, this strain utilizes 12 patented inventions related to gut health, immune regulation, and bone health. It has been widely used in infant nutrition, yogurts, and dietary supplements.
2.
Lactobacillus paracasei K56: Isolated from the intestines of healthy Chinese infants, clinical evidence shows this strain effectively reduces body fat, visceral fat, and waist circumference. It has garnered nine Chinese patents and is backed by 12 published research studies.
3.
Bifidobacterium animalis subsp. lactis CP-9: Derived from breast milk of healthy Chinese mothers, this strain is patented in China for its anti-obesity effects and its potential in treating or preventing jaundice.
As a representative of the Chinese probiotic industry, BioFlag demonstrated its capabilities across the entire industrial chain, showcasing its extensive library of more than 3,500 probiotic strains and over 30 functional screening platforms. The company holds more than 130 patents and has published over 100 scientific papers, all while maintaining international certifications including GMP, FSSC22000, and HALAL.
BioFlag manufactures a diverse range of dosage forms, including powders, tablets, capsules, and more. During the exhibition, BioFlag aimed to establish partnerships with dozens of companies and institutions from Europe, North America, and other regions. A company spokesperson stated, “With nearly two decades of experience in effective probiotics, we continue to advocate innovation in research and development and intelligent manufacturing to provide outstanding health solutions to customers worldwide.”
For more information, visit
BioFlag.
In summary, BioFlag's participation in the Vitafoods Europe 2025 exhibition solidifies its commitment to leading the probiotics industry through innovative solutions that meet the changing health needs of consumers globally.